Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 60.55 ($0.76) and traded as low as GBX 57 ($0.71). Tissue Regenix Group shares last traded at GBX 57 ($0.71), with a volume of 18,582 shares traded.
Tissue Regenix Group Stock Down 2.6 %
The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The stock has a market capitalization of £40.60 million, a PE ratio of -5,700.00 and a beta of 1.61. The business has a 50 day moving average of GBX 58.80 and a two-hundred day moving average of GBX 60.55.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What Do S&P 500 Stocks Tell Investors About the Market?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Profitably Trade Stocks at 52-Week Highs
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
